Erwin Tomasich

797 total citations
31 papers, 547 citations indexed

About

Erwin Tomasich is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Erwin Tomasich has authored 31 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Erwin Tomasich's work include Cancer Immunotherapy and Biomarkers (10 papers), Epigenetics and DNA Methylation (8 papers) and Brain Metastases and Treatment (4 papers). Erwin Tomasich is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Epigenetics and DNA Methylation (8 papers) and Brain Metastases and Treatment (4 papers). Erwin Tomasich collaborates with scholars based in Austria, Germany and Hungary. Erwin Tomasich's co-authors include Maximilian Marhold, Gerwin Heller, Michael Krainer, Peter Horak, Reinhard Horvat, Leonhard Müllauer, Christoph Minichsdorfer, Sabine Zöchbauer‐Müller, Barbara Ziegler and Andreas Spittler and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Erwin Tomasich

29 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erwin Tomasich Austria	13	336	187	179	120	72	31	547
Amandeep Bhamra United Kingdom	8	334 1.0×	154 0.8×	118 0.7×	78 0.7×	136 1.9×	12	496
Alf Spitschak Germany	16	465 1.4×	243 1.3×	244 1.4×	67 0.6×	73 1.0×	24	694
Moitza Principe Italy	10	359 1.1×	228 1.2×	215 1.2×	59 0.5×	115 1.6×	14	599
Jonathan T. Lei United States	11	263 0.8×	130 0.7×	175 1.0×	207 1.7×	97 1.3×	30	585
Tianshui Sun China	9	456 1.4×	179 1.0×	137 0.8×	85 0.7×	54 0.8×	14	556
Anup Sharma United States	12	495 1.5×	159 0.9×	237 1.3×	72 0.6×	73 1.0×	23	668
Adrian P. Rybak Canada	12	450 1.3×	157 0.8×	265 1.5×	174 1.4×	55 0.8×	17	644
Dian-na Gu China	12	306 0.9×	282 1.5×	151 0.8×	72 0.6×	70 1.0×	27	516
Karama Asleh Canada	12	275 0.8×	217 1.2×	314 1.8×	177 1.5×	121 1.7×	25	669
Shuet Theng Lee Singapore	5	576 1.7×	216 1.2×	173 1.0×	67 0.6×	78 1.1×	5	715

Countries citing papers authored by Erwin Tomasich

Since Specialization

Citations

This map shows the geographic impact of Erwin Tomasich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin Tomasich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin Tomasich more than expected).

Fields of papers citing papers by Erwin Tomasich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwin Tomasich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin Tomasich. The network helps show where Erwin Tomasich may publish in the future.

Co-authorship network of co-authors of Erwin Tomasich

This figure shows the co-authorship network connecting the top 25 collaborators of Erwin Tomasich. A scholar is included among the top collaborators of Erwin Tomasich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erwin Tomasich. Erwin Tomasich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Çifçi, Didem, Erwin Tomasich, Maximilian J. Mair, et al.. (2025). Density and entropy of immune cells within the tumor microenvironment of primary tumors and matched brain metastases. Acta Neuropathologica Communications. 13(1). 34–34. 1 indexed citations

Mair, Maximilian J., Sabrina Hartenbach, Erwin Tomasich, et al.. (2025). Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma. European Journal of Nuclear Medicine and Molecular Imaging. 52(8). 2771–2781. 1 indexed citations

Mair, Maximilian J., Gerwin Heller, Erwin Tomasich, et al.. (2025). Clinical characteristics, molecular reclassification trajectories and DNA methylation patterns of long- and short-term survivors of WHO grade II and III glioma. Journal of Neurology. 272(3). 210–210. 1 indexed citations

Tomasich, Erwin, Jakob Mühlbacher, Katharina Wöran, et al.. (2024). Immune cell distribution and DNA methylation signatures differ between tumor and stroma enriched compartment in pancreatic ductal adenocarcinoma. Translational research. 271. 40–51. 2 indexed citations

Tomasich, Erwin, Maximilian J. Mair, Ariane Steindl, et al.. (2024). 450MO Characterization of tumor-infiltrating lymphocytes and tumor-associated macrophages within the tumor microenvironment of primary tumors and matched brain metastases. Annals of Oncology. 35. S409–S410.

Berger, J.M., Erwin Tomasich, M. Korpan, et al.. (2024). 23P Non-small cell lung cancer DNA methylation profiles correlate with immune checkpoint inhibitor response. Immuno-Oncology Technology. 24. 100905–100905. 1 indexed citations

Tomasich, Erwin, Helmut Ringl, Gerwin Heller, et al.. (2024). DNA Methylation Signatures Correlate with Response to Immune Checkpoint Inhibitors in Metastatic Melanoma. Targeted Oncology. 19(2). 263–275. 11 indexed citations

Tomasich, Erwin, Helmut Ringl, Gerwin Heller, et al.. (2023). Correlation of DNA methylation signatures with response to immune checkpoint inhibitors in metastatic melanoma.. Journal of Clinical Oncology. 41(16_suppl). 9561–9561. 1 indexed citations

Tomasich, Erwin, Ariane Steindl, Rainer Puhr, et al.. (2023). Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer. Clinical Cancer Research. 29(16). 3225–3236. 14 indexed citations

10.

Steindl, Ariane, Arne Kienzle, Erwin Tomasich, et al.. (2023). 537P S100A9 serum levels are associated with survival prognosis in patients with brain metastases. Annals of Oncology. 34. S405–S405. 1 indexed citations

11.

Mair, Maximilian J., Gerwin Heller, Rainer Puhr, et al.. (2022). Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns. Clinical Cancer Research. 28(20). 4565–4573. 8 indexed citations

12.

Millesi, Matthias, Johannes A. Hainfellner, Anna S. Berghoff, et al.. (2022). DNA Methylation Associates With Clinical Courses of Atypical Meningiomas: A Matched Case–Control Study. Frontiers in Oncology. 12. 811729–811729. 5 indexed citations

13.

Starzer, Angelika M., Gerwin Heller, Erwin Tomasich, et al.. (2022). DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 10(3). e003420–e003420. 19 indexed citations

14.

Tobias, Joshua, Sandra Högler, Karin Baier, et al.. (2022). Active immunization with a Her-2/neu-targeting Multi-peptide B cell vaccine prevents lung metastases formation from Her-2/neu breast cancer in a mouse model. Translational Oncology. 19. 101378–101378. 10 indexed citations

15.

Tomasich, Erwin, et al.. (2020). Loss of HCRP1 leads to upregulation of PD-L1 via STAT3 activation and is of prognostic significance in EGFR-dependent cancer. Translational research. 230. 21–33. 10 indexed citations

16.

Aydemir, Duygu, et al.. (2020). Delineation of cell death mechanisms induced by synergistic effects of statins and erlotinib in non-small cell lung cancer cell (NSCLC) lines. Scientific Reports. 10(1). 959–959. 39 indexed citations

17.

Altenberger, Corinna, Gerwin Heller, Barbara Ziegler, et al.. (2017). SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers. Molecular Cancer. 16(1). 1–1. 106 indexed citations

18.

Heller, Gerwin, Julia Etzler, Hubert Hackl, et al.. (2015). EVI1 promotes tumor growth via transcriptional repression of MS4A3. Journal of Hematology & Oncology. 8(1). 28–28. 24 indexed citations

19.

Marhold, Maximilian, Erwin Tomasich, Ahmed El‐Gazzar, et al.. (2014). HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells. Molecular Cancer Research. 13(3). 556–564. 72 indexed citations

20.

Horak, Peter, Erwin Tomasich, Petr Vaňhara, et al.. (2014). TUSC3 Loss Alters the ER Stress Response and Accelerates Prostate Cancer Growth in vivo. Scientific Reports. 4(1). 3739–3739. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact